Published Online
on February 2, 2009

A more recent version of this article appeared on February 17, 2009

This Article Full Text (PDF) All Versions of this Article: 119/6/828    most recent CIRCULATIONAHA.108.799403v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Werkum, J. W. Articles by ten Berg, J. M. Search for Related Content PubMed PubMed Citation Articles by van Werkum, J. W. Articles by ten Berg, J. M. Related Collections Risk Factors Arterial thrombosis Thrombosis risk factors Catheter-based coronary interventions: stents Related Article

Submitted on June 16, 2008
Accepted on November 30, 2008

Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis. An Analysis of 431 Cases

Jochem W. van Werkum MD, PhD, Antonius A.C.M. Heestermans MD, Fleur I. de Korte MD, Johannes C. Kelder MD, Maarten-Jan Suttorp MD, PhD, Benno J.W.M. Rensing MD, PhD, Bastiaan Zwart MSc, PhD, B. R. Guus Brueren MD, PhD, Jacques J. Koolen MD, PhD, Jan-Henk E. Dambrink MD, PhD, Arnoud W.J. van't Hof MD, PhD, Freek W.A. Verheugt MD, PhD, and Jurriën M. ten Berg MD, PhD^*

From the Department of Cardiology, St. Antonius Hospital (J.W.v.W., F.I.d.K., J.C.K., M.-J.S., B.J.W.M.R., B.Z., J.M.t.B.), Nieuwegein, Netherlands; the Department of Cardiology, Isala Klinieken (A.A.C.M.H., J.-H.E.D., A.W.J.v.H.), Zwolle, Netherlands; the Department of Cardiology, Catharina Hospital (B.R.G.B., J.J.K.), Eindhoven, Netherlands; and the Department of Cardiology, UMC St. Radboud (J.W.v.W., F.W.A.V.), Nijmegen, Netherlands.

^* To whom correspondence should be addressed. E-mail: berg03{at}antonius.net.

Background—There are limited data on the long-term clinical outcome after an angiographically confirmed (definite) stent thrombosis (ST).

Methods and Results—Four hundred thirty-one consecutive patients with a definite ST were enrolled in this multicenter registry. The primary end point was the composite of cardiac death and definite recurrent ST. Secondary end points were all-cause death, cardiac death, definite recurrent ST, definite and probable recurrent ST, any myocardial infarction, and any target-vessel revascularization. The primary end point occurred in 111 patients after a median follow-up of 27.1 months. The estimated cumulative event rates at 30 days and 1, 2, and 3 years were 18.0%, 23.6%, 25.2%, and 27.9%, respectively. The cumulative incidence rates of definite recurrent ST, definite or probable recurrent ST, any myocardial infarction, and any target-vessel revascularization were 18.8%, 20.1%, 21.3%, and 32.0%, respectively, at the longest available follow-up. Independent predictors for the primary end point were diabetes mellitus, total stent length, severe calcification, American College of Cardiology/American Heart Association B2-C lesions, TIMI (Thrombolysis In Myocardial Infarction) flow grade <3 after percutaneous coronary intervention, and left ventricular ejection fraction <45%. The implantation of an additional coronary stent during the first ST was also associated with unfavorable outcome. Clinical outcome was not affected by the type of previously implanted stent (drug-eluting or bare-metal stent) or the category of ST (early versus late).

Conclusions—The long-term clinical outcome after a first definite ST is unfavorable, with a high mortality and recurrence rate. Diabetes mellitus, left ventricular ejection fraction <45%, long total stent length, complex coronary lesions, TIMI flow grade <3 after percutaneous coronary intervention, and implantation of an additional coronary stent during the emergent percutaneous coronary intervention for the ST were associated with this unfavorable outcome.

Key words: stents • thrombosis • risk factors

Related Article:

Clinical Summaries
Circulation 2009 119: 765-767. [Extract] [Full Text]

This article has been cited by other articles:

				R. C. Becker, J. Scheiman, H. L. Dauerman, F. Spencer, S. Rao, M. Sabatine, D. A. Johnson, F. Chan, N. S. Abraham, E. M.M. Quigley, et al. Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2261 - 2276. [Abstract] [Full Text] [PDF]

				R. P. Giugliano and E. Braunwald The Year in Non-ST-Segment Elevation Acute Coronary Syndrome. J. Am. Coll. Cardiol., October 13, 2009; 54(16): 1544 - 1555. [Full Text] [PDF]

				D. Adlam, R. Ayers, and K. M. Channon Intimal Dissection Causing Late Thrombosis of a Covered Stent: Optical Coherence Tomography Appearances Circ Cardiovasc Interv, August 1, 2009; 2(4): 359 - 360. [Full Text] [PDF]

				J. M. Lasala, D. A. Cox, D. Dobies, K. Baran, W. B. Bachinsky, E. W. Rogers, J. A. Breall, D. H. Lewis, A. Song, R. M. Starzyk, et al. Drug-Eluting Stent Thrombosis in Routine Clinical Practice: Two-Year Outcomes and Predictors From the TAXUS ARRIVE Registries Circ Cardiovasc Interv, August 1, 2009; 2(4): 285 - 293. [Abstract] [Full Text] [PDF]